Trial Profile
An open-label, crossover clinical study to investigate the effects of Ojeoksan on the pharmacokinetics of Celecoxib capsules in healthy male volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Ankylosing spondylitis; Cervicobrachial syndrome; Dysmenorrhoea; Familial adenomatous polyposis; Juvenile rheumatoid arthritis; Non-small cell lung cancer; Osteoarthritis; Pain; Periarthritis; Rheumatic disorders; Rheumatoid arthritis; Stomatitis; Tendinitis; Tenosynovitis
- Focus Pharmacokinetics
- Acronyms KHUH-K01
- 15 Dec 2017 New trial record